Pharmanutra S.p.A. (BIT:PHN)

Market Cap	521.46M
Revenue (ttm)	127.15M
Net Income (ttm)	17.45M
Shares Out	9.60M
EPS (ttm)	1.82
PE Ratio	29.86
Forward PE	24.58
Dividend	1.00 (1.84%)
Ex-Dividend Date	May 5, 2025

Volume	7,029
Average Volume	14,169
Open	54.30
Previous Close	54.30
Day's Range	53.80 - 54.70
52-Week Range	38.75 - 60.00
Beta	0.35
RSI	57.35
Earnings Date	Mar 13, 2026

About Pharmanutra

Pharmanutra S.p.A., a pharmaceutical and nutraceutical company, researches, designs, develops, and markets nutritional supplements and medical devices in Italy, Europe, the Middle East, South America, Far East, and internationally. The company produces and distributes raw materials and active ingredients for the food, pharmaceutical, and dietary supplement industries. It also offers iron deficiency, inflammation, mineral and vitamin, muscle and joint, sports nutrition, ophthalmic, and night rest products; and medical instrumentation and softwar...

• Industry: Drug Manufacturers - Specialty & Generic
• Sector: Healthcare
• Founded: 2003
• Employees: 118
• Stock Exchange: Borsa Italiana
• Ticker Symbol: PHN

Financial Performance

In 2024, Pharmanutra's revenue was 116.15 million, an increase of 15.33% compared to the previous year's 100.71 million. Earnings were 16.61 million, an increase of 29.43%.